Alan Fuhrman Insider Trading $SYBX SYNLOGIC, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Alan Fuhrman.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Alan Fuhrman. Alan Fuhrman is Senior Vice President & CFO in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and Director in Esperion Therapeutics, Inc. ($ESPR) and Chief Financial Officer in Mirna Therapeutics, Inc. ($MIRN) and Director in Loxo Oncology, Inc. ($LOXO) and Director in SpringWorks Therapeutics, Inc. ($SWTX).

Alan Fuhrman in SYNLOGIC, INC.

Trading Symbol: SYBX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Alan Fuhrman: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 14 2016
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Alan Fuhrman in SYNLOGIC, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACHV, ESPR, LOXO, SWTX, SYBX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 14 2016MIRNMirna Therapeutics ...Fuhrman AlanChief Financial Off ...Option ExerciseA4.3660,000261,60060,000
Sep 30 2015MIRNMirna Therapeutics ...Fuhrman AlanChief Financial Off ...Option ExerciseA7.00167,1801,170,260167,180

Page:   1